Effect of Corticosteroids in 10 Cases of Methimazole-Induced Agranulocytosis
スポンサーリンク
概要
- 論文の詳細を見る
The effect of corticosteroids on the inception of remission was investigated in 10 patients with methimazole induced agranulocytosis. While remission started 6.00±0.92 days (mean±SE) after discontinuation of methimazole in 6 patients to whom corticosteroids were administered immediately after the cessation of methimazole treatment, it started at a significantly later date (9.25±0.48days after discontinuation of methimazole) in 4 patients in whom the corticosteroid treatment was started 5.5±0.5 days after methimazole ceased to be used. The results suggested that corticosteroids may quicken the recovery from methimazole-induced agranulocytosis.
- 社団法人 日本内分泌学会の論文
著者
-
Morii Hirotoshi
Second Department Of Internal Medicine Osaka City University Medical School
-
HAMADA NOBORU
Second Department of Internal Medicine, Osaka City University
-
ITOH KUNIHIKO
Itoh Hospital
-
MIMURA TAKASHI
Itoh Hospital
-
MOTOTANI NAOKO
Itoh Hospital
-
NISHIKAWA YOSHIHIKO
Itoh Hospital
-
MORII HIROTOSHI
Second Department of Internal Medicine Osaka City University
-
HAMADA NOBORU
Second Department of Internal Medicine, Osaka City University Medical School
関連論文
- -0146- Role of endothelium in hypotensive action of acetylcholine and bradylinin in spontaneously hypertensive rat.(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
- Efficacy and safety of long-term oral falecalcitriol treatment in patients with renal osteodystrophy
- Clinical trial of in-situ hybridization method for the rapid diagnosis of sepsis
- Idiopathic portal hypertension associated with high serum titer of autoantibodies and liver dysfunction
- Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
- Efficacy of low-dose, intermittent eel calcitonin treatment for osteoporosis
- Synergistic Enhancement by 12-O-Tetradecanoylphorbol-13-acetate and Dibutyryl cAMP of 1α, 25-Dihydroxyvitamin D_3 Actionin Human Promyelocytic Leukemic HL-60 Cells
- Efficacy and safety of oral falecalcitriol in reducing parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism
- Insulin Secretion in Patients with Hyperthyroidism: in Relation to Abnormalities in Carbohydrate Metabolism
- Closer Correlation between Serum Triiodothyronine and Basal Metabolic Rate during Antithyroid Drug Treatment in Patients with Graves Disease
- Statement on the diagnosis and management of osteoporosis from the Consensus Development Conference at the Second International Conference on Osteoporosis,Osaka 1997
- A Case Report on Disequilibrium Hypercalcemia in Hyperthyroidism : Comparison of Calcium Metabolism with Other Patients with Hyperthyroidism
- Effect of Corticosteroids in 10 Cases of Methimazole-Induced Agranulocytosis
- Raloxifene: Basic Science to Clinical Outcomes
- Preventive Effect of Salmon Calcitonin on Restraint-Induced Gastric Ulcer in Rats
- Secretion of Gastrin and Calcitonin after Ingestion of Meat Extract in Patients with Peptic Ulcer
- A Case Report of Turner's Sydrome with Ring X Chromosome
- Effects of Uremic Serum on 1, 25-Dihydroxyvitamin D3-Induced Differentiation of a Human Promyelocytic Leukemia Cell Line, HL-60
- Lipoprotein Metabolism in Normolipidemic Obese Women during Very Low Calorie Diet:Changes in High Density Lipoprotein
- Effects of Dietary Phosphorus Restriction on Secondary Hyperparathyroidism in Hemodialysis Patients during Intermittent Oral High-dose 1, 25(OH)2D3 Treatment
- Obesity as a Determinant of Regional Bone Mineral Density
- Bone Mineral Loss in Patients on Maintenance Hemodialysis with Hyperphosphatemia Treated with 1α-Hydroxycholecalciferol and Calcium Carbonate
- Total and Regional Bone Mineral Content in Patients with Non-Insulin Dependent Diabetes Mellitus
- Cardiac Function and Exercise Capacity of Diabetic Patients
- Calcium Metabolism in Diabetes Mellitus
- Nutrition and Renal Osteodystrophy